The AHA’s Health Research & Educational Trust affiliate and the Centers for Disease Control and Prevention today announced a three-year initiative to improve the implementation of infection prevention and control efforts in U.S. hospitals. The project will work with state hospital associations, state health departments, the Centers for Medicare & Medicaid Services’ Quality Improvement Networks, AHA’s American Society for Healthcare Engineering affiliate and other partners to reduce central line-associated bloodstream infections, catheter-associated urinary tract infections, Clostridium difficile infections and methicillin-resistant Staphylococcus aureus infections in targeted acute care hospitals. “We welcome the opportunity to work with CDC on the important issue of infection prevention,” said Maulik Joshi, president of HRET and associate executive vice president of AHA. “This project will build on our national work that has successfully reduced CAUTI and CLABSI rates and improved patient care.”

Related News Articles

Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
A coalition of 40 health care and public health organizations, including the AHA, today urged the Senate to quickly pass the Pandemic and All-Hazards…
Headline
The House of Representatives last night passed legislation (H.R. 269) that includes the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary of Preparedness and Response will host a Jan. 29 webinar on its new toolkit.
Insights and Analysis
Reynolds says the Institute is poised to be a convener of the AHA’s diverse constituency and will elevate the relevance of its expertise and educational…
Headline
The Centers for Medicare…